Harrow (HROW) Cost of Revenue (2014 - 2026)
Harrow (HROW) posted Cost of Revenue of $20.3 million for Q2 2026, up 18.3% on a QoQ basis from $17.2 million in Q1 2026, and up 25.06% year-over-year from $16.2 million in Q2 2025.
Analysis
Harrow (HROW) Cost of Revenue (2014 - 2026) Analysis & Trends
Harrow has reported Cost of Revenue for 13 years, with the latest figure at $20.3 million in Q2 2026.
- On a quarterly basis, Cost of Revenue rose 25.06% year-over-year to $20.3 million in Q2 2026; TTM through Jun 2026 was $73.6 million, a 27.16% increase from a year earlier, with the FY2025 full-year figure at $67.9 million, up 37.95% from the prior year.
- Cost of Revenue was $20.3 million for Q2 2026 at Harrow, up from $17.2 million in the prior quarter.
- The five-year high for Cost of Revenue was $20.3 million in Q2 2026, with the low at $6.0 million in Q1 2022.
- Average Cost of Revenue over 5 years is $12.2 million, with a median of $11.7 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2026: Cost of Revenue jumped 83.33% in 2023, then grew 10.53% in 2026.
- Over 5 years, Cost of Revenue stood at $6.2 million in 2022, then surged by 83.33% to $11.3 million in 2023, then climbed by 25.07% to $14.1 million in 2024, then jumped by 30.65% to $18.5 million in 2025, then grew by 9.91% to $20.3 million in 2026.
- The last three Cost of Revenue figures came in at $20.3 million (Q2 2026), $17.2 million (Q1 2026), and $18.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 8.05 Bn |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 4.29 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 4.40 Bn |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | 3.71 Bn |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | 4.09 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 3.51 Bn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | - |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 104.96 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 99.50 Mn |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 50.36 Mn | 20.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.30 Mn |
| Mar 31, 2026 | 17.16 Mn |
| Dec 31, 2025 | 18.47 Mn |
| Sep 30, 2025 | 17.71 Mn |
| Jun 30, 2025 | 16.23 Mn |
| Mar 31, 2025 | 15.52 Mn |
| Dec 31, 2024 | 14.14 Mn |
| Sep 30, 2024 | 12.02 Mn |
| Jun 30, 2024 | 12.54 Mn |
| Mar 31, 2024 | 10.55 Mn |
| Dec 31, 2023 | 11.30 Mn |
| Sep 30, 2023 | 10.07 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 8.27 Mn |
| Dec 31, 2022 | 6.17 Mn |
| Sep 30, 2022 | 6.72 Mn |
| Jun 30, 2022 | 6.53 Mn |
| Mar 31, 2022 | 5.96 Mn |
| Dec 31, 2021 | 5.08 Mn |
| Sep 30, 2021 | 4.95 Mn |